The clinical significance of plasma clusterin and Aβ in the longitudinal follow-up of patients with Alzheimer's disease.

Jung-Lung HsuWei-Ju LeeYi-Chu LiaoShuu-Jiun WangJong-Ling Fuh

Published in: Alzheimer's research & therapy (2017)

Plasma clusterin could serve as a biomarker for the severity of cognitive decline. Plasma Aβ in ApoE4-positive AD could predict long-term agitation/aggression symptoms.

Keyphrases

cognitive decline
mild cognitive impairment
high fat diet
adipose tissue
skeletal muscle
sleep quality